Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel in Hand Osteoarthritis
NCT00171665Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Diclofenac Sodium Gel 1% with Vehicle Gel (2 arms). Primary endpoints: Osteoarthritis pain intensity in target hand at 6 weeks, Total Australian/Canadian Osteoarthritis Hand Index score at 6 weeks and 1 more. Started May 2005; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00171665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171665.